Moxifloxacin Hydrochloride Tablets

DRUG2 trials

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

COPDMyelofibrosis

Phase 1

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.

CompletedNCT07116915

Guangdong Hengrui Pharmaceutical Co., LtdCOPD

Start: 2025-08-11End: 2026-08-14Updated: 2026-09-09

QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants

Active, not recruitingNCT07708272

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Myelofibrosis

Start: 2026-07-30End: 2027-02-01Updated: 2026-08-07